Insider Trading History of Abdun-nabi Daniel

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Abdun-nabi Daniel since 2015. This trader's CIK number is 1380187. At the time of last reporting, Abdun-nabi Daniel was the Officer of Aptevo Therapeutics Inc.. (stock ticker symbol APVO). Also see all insider trading activities at Aptevo Therapeutics Inc..

Note that in the past Abdun-Nabi Daniel also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aptevo Therapeutics Inc. (APVO) by Abdun-nabi Daniel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 APVO 0 $0 0 $0 1 $0
2023 APVO 0 $0 0 $0 4,165 $0
2022 APVO 0 $0 0 $0 298 $0
2019 APVO 16,667 $15,000 0 $0 0 $0

Yearly summary of insider trading at Emergent Biosolutions Inc. (EBS) by Abdun-nabi Daniel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 EBS 0 $0 14,565 $846,328 0 $0
2018 EBS 0 $0 158,006 $9,255,406 111,445 $1,514,353
2017 EBS 0 $0 109,748 $4,305,716 123,176 $2,187,882
2016 EBS 0 $0 26,102 $1,095,495 0 $0
2015 EBS 0 $0 63,209 $2,468,632 67,349 $1,294,630


Insider trading activities at 2 companies by Abdun-nabi Daniel:

1. Aptevo Therapeutics Inc. (APVO)

2. Emergent Biosolutions Inc. (EBS)

Table 1. Insider trading of Aptevo Therapeutics Inc. (APVO) by Abdun-nabi Daniel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-17 APVO Option Ex 1 .00 0
2023-08-09 APVO Option Ex 3,571 .00 0
2023-06-01 APVO Option Ex 297 .00 0
2023-06-01 APVO Option Ex 297 .00 0
2022-06-01 APVO Option Ex 298 .00 0
2019-06-25 APVO Buy 16,667 .90 15,000

Table 2. Insider trading of Emergent Biosolutions Inc. (EBS) by Abdun-nabi Daniel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-04 EBS Sale 14,565 58.11 846,328
2018-09-14 EBS Option Ex 28,220 13.38 377,583
2018-09-17 EBS Sale 1,319 65.00 85,735
2018-09-17 EBS Option Ex 1,319 13.38 17,648
2018-09-14 EBS Sale 28,220 65.00 1,834,300
2018-09-04 EBS Option Ex 60,000 13.38 802,800
2018-09-04 EBS Sale 60,000 60.54 3,632,280
2018-09-05 EBS Sale 30,776 59.49 1,830,956
2018-06-05 EBS Sale 15,785 52.11 822,619
2018-01-02 EBS Option Ex 21,906 14.44 316,322
2018-01-02 EBS Sale 21,906 47.91 1,049,516
2017-12-13 EBS Option Ex 20,000 14.44 288,800
2017-12-13 EBS Sale 20,000 45.99 919,800
2017-11-03 EBS Option Ex 31,508 18.23 574,548
2017-11-03 EBS Sale 31,508 42.71 1,345,706
2017-09-27 EBS Option Ex 15,000 22.03 330,450
2017-09-27 EBS Sale 15,000 39.92 598,770
2017-08-31 EBS Option Ex 15,000 22.03 330,450
2017-08-31 EBS Sale 15,000 37.21 558,150
2017-02-27 EBS Option Ex 3,662 30.63 112,167
2017-01-10 EBS Sale 28,240 31.28 883,290
2017-01-10 EBS Option Ex 38,006 14.51 551,467
2016-06-01 EBS Sale 8,699 43.74 380,494
2016-05-20 EBS Sale 8,701 42.00 365,442
2016-04-18 EBS Sale 8,702 40.17 349,559
2015-12-23 EBS Option Ex 40,354 18.90 762,690
2015-12-24 EBS Option Ex 22,855 18.90 431,959
2015-12-23 EBS Sale 40,354 38.99 1,573,402
2015-12-24 EBS Sale 22,855 39.17 895,230
2015-12-15 EBS Option Ex 4,140 24.15 99,981

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abdun-nabi Daniel (Officer of Aptevo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.